Hospira Sues B. Braun Over Infusion-Pump System Patents

Hospira Inc. (HSP), a maker of acute-care products, sued a U.S. unit of Germany’s B. Braun Melsungen AG alleging infringement of patents for drug-infusion pump technology.

B. Braun Medical Inc., based in Bethlehem, Pennsylvania, is using inventions that belong to Hospira, of Lake Forest, Illinois, by making and selling its drug-delivery systems without permission, Hospira contends in a complaint filed yesterday in federal court in Wilmington, Delaware.

“Hospira is the owner of the entire right, title and interest” in the patents, and Braun should pay damages for lost profits and legal fees and be prohibited from its wrongful actions after a jury trial, plaintiff’s lawyers said in court papers.

Hospira itself was sued in New York Federal court in February over a canceled influenza-vaccine supply contract by GlaxoSmithKline Plc., which questioned the quality of the product. The case is continuing.

Jason Ford, a B. Braun spokesman, didn’t immediately reply to voice and e-mail requests for comment on the patent action.

The case is Hospira Inc. v. B. Braun Medical Inc., 13-cv-00819, U.S. District Court, District of Delaware (Wilmington).

To contact the reporter on this story: Phil Milford in Wilmington, Delaware, at pmilford@bloomberg.net.

To contact the editor responsible for this story: Michael Hytha at mhytha@bloomberg.net.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.